<DOC>
	<DOCNO>NCT00448487</DOCNO>
	<brief_summary>3054 diabetic patient screen Haptoglobin Phenotype part ICARE study ( NCT00220831 ) composite I CARE Registry , 1434 Hp 2-2 patient treat part I CARE study vitamin E v . Placebo , study recently terminate due significant difference group data send publication . All patient passively follow since April 2005 cardiovascular event . We decide continue follow patient till end December 2007 determine incidence CVD theses patient pre stratify Haptoglobin Phenotype .</brief_summary>
	<brief_title>Haptoglobin Phenotype Cardiovascular Complications Diabetic Patients</brief_title>
	<detailed_description>3054 diabetic patient Clalit Medical Services screen Haptoglobin Phenotype part ICARE study ( NCT00220831 ) composite I CARE registry , 1434 Hp 2-2 patient treat part I CARE study vitamin E v . Placebo , study recently terminate due significant difference group data send publication . During follow period I CARE study 3054 registry patient follow passive way , mean patient call follow visit report CVD event centrally collect patient 's Hospital admission summary . Admission summary collect use computerized system Clalit Health Services assure ever patient registry hospitalize ever reason study coordination would aware receive admission summary . An event adjudication committee adjudicate event blind fashion determine nature event . 1434 patient treat vitamin E placebo I CARE study also follow follow-up telephone call . I CARE study officially terminate decide continue follow whole 3054 registry patient manner complete nearly 3 year follow determine prospective manner incidence CVD event Diabetic patient pre-stratified Haptoglobin type .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<criteria>These patient I CARE registry criterion I CARE study Recruitment phase . Diabetic patient age 55 Patient take antioxidant treatment ask stop , ca n't include study Patients CVD incident ( MI , Stroke , TIA ) , Unstable angina pectoris , Uncontrolled HTN , wait month stabilization include study Allergy Vitamin E</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>Cardiovascular Disease</keyword>
	<keyword>Haptoglobin</keyword>
</DOC>